Home Cart 0 Sign in  
X

[ CAS No. 7307-08-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 7307-08-6
Chemical Structure| 7307-08-6
Chemical Structure| 7307-08-6
Structure of 7307-08-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 7307-08-6 ]

Related Doc. of [ 7307-08-6 ]

Alternatived Products of [ 7307-08-6 ]

Product Details of [ 7307-08-6 ]

CAS No. :7307-08-6 MDL No. :MFCD19301657
Formula : C11H20O2 Boiling Point : -
Linear Structure Formula :- InChI Key :GJMUCDMIIVSROW-UHFFFAOYSA-N
M.W : 184.28 Pubchem ID :581379
Synonyms :

Calculated chemistry of [ 7307-08-6 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.82
Num. rotatable bonds : 6
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 55.39
TPSA : 34.14 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.77 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.48
Log Po/w (XLOGP3) : 2.33
Log Po/w (WLOGP) : 2.61
Log Po/w (MLOGP) : 1.95
Log Po/w (SILICOS-IT) : 2.88
Consensus Log Po/w : 2.45

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.05
Solubility : 1.63 mg/ml ; 0.00882 mol/l
Class : Soluble
Log S (Ali) : -2.69
Solubility : 0.38 mg/ml ; 0.00206 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.64
Solubility : 0.424 mg/ml ; 0.0023 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.66

Safety of [ 7307-08-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 7307-08-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 7307-08-6 ]
  • Downstream synthetic route of [ 7307-08-6 ]

[ 7307-08-6 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 556-24-1 ]
  • [ 108-10-1 ]
  • [ 7307-08-6 ]
YieldReaction ConditionsOperation in experiment
43% With potassium <i>tert</i>-butylate In N,N-dimethyl-formamide at 50℃; Inert atmosphere N, N-dimethyl formamide (DMF) (1L) and potassium tert-butoxide (135. 0g, 1. 2mol) to 50 °C heated under nitrogen. Methyl 3-methyl butanoate (86. 0g, 0. 75mmol), then in the DMF 100 ml of 4-methyl pentane-2-one (50g, 1mol) by dripping from the solution by adding through funnel. GC is observed by the progress of the reaction. When the reaction is completed, the mixture is cooled to room temperature, 20percent H 2 SO 4 soln. neutralized slowly. By adding water (300 ml), 2 layer is formed. 2, 8- dimethyl nonane -4, 6-pyrimidinedione layer including, purified by using a vacuum distillation, 40g pink (43percent yield) oil is obtained.
1.5 g With potassium <i>tert</i>-butylate In N,N-dimethyl-formamide at 50℃; for 6 h; Inert atmosphere First, 25 mL of N,N-dimethylformamide (abbreviation: DMF) and 5.59 g of potassium tertiary butoxide (abbreviation: t-BuOK) were placed in a three-necked flask, and the inside of the flask was purged with nitrogen. Displace and heat to 50°C. To the solution, 3.5 g of methyl isovalerate and 2.0 g of 4-methyl-2-pentanone dissolved in 2.5 mL of DMF were added and stirred at 50° C. for 6 hours. The resulting solution was cooled to room temperature, suction-filtered using 6.8 mL of 20percent sulfuric acid and 25 mL of water, and the residue was washed with toluene. The organic layer was extracted from the filtrate with toluene and distilled to remove the solvent from the extract. The obtained residue was purified by distillation under reduced pressure to obtain 1.5 g of Hdivm (yellow oil) of the desired product. The synthetic scheme of Step 1 is shown below (A-1).
Reference: [1] Patent: JP2015/212297, 2015, A, . Location in patent: Paragraph 0101; 0102
[2] Synthetic Communications, 2007, vol. 37, # 23, p. 4111 - 4115
[3] Patent: TWI612051, 2018, B, . Location in patent: Paragraph 0188; 0190; 0191
  • 2
  • [ 107977-25-3 ]
  • [ 7307-08-6 ]
Reference: [1] Journal of Organic Chemistry, 2000, vol. 65, # 18, p. 5806 - 5816
  • 3
  • [ 108-64-5 ]
  • [ 108-10-1 ]
  • [ 7307-08-6 ]
Reference: [1] Journal of the American Chemical Society, 1950, vol. 72, p. 1352,1353, 1356
  • 4
  • [ 108-10-1 ]
  • [ 7307-08-6 ]
Reference: [1] Journal of Organic Chemistry, 2000, vol. 65, # 18, p. 5806 - 5816
  • 5
  • [ 503-74-2 ]
  • [ 7307-08-6 ]
Reference: [1] Zhurnal Obshchei Khimii, 1959, vol. 29, p. 1458,1460; engl. Ausg. S. 1432, 1434
  • 6
  • [ 34136-03-3 ]
  • [ 7307-08-6 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1973, vol. 46, p. 632 - 634
Same Skeleton Products
Historical Records